During the past decade, Southbay Oncology Hematology Partners conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southbay Oncology Hematology Partners" #1 sponsor was "Genentech, Inc." with 3 trials, followed by "Novartis Pharmaceuticals" with 3 trials sponsored, "Celgene" with 1 trials sponsored, "Geron Corporation" with 1 trials sponsored and "Heron Therapeutics" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southbay Oncology Hematology Partners" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Southbay Oncology Hematology Partners" are "Breast Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Leukemia, Myeloid, Chronic Phase" (1 trials), "Locally Recurrent or Metastatic Breast Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Southbay Oncology Hematology Partners" in a lesser frequency.

Most popular intervention types in "Southbay Oncology Hematology Partners" are "Drug" (9 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "placebo" (2 trials), "APF530" (1 trials), "Bevacizumab" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southbay Oncology Hematology Partners" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Southbay Oncology Hematology Partners". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Southbay Oncology Hematology Partners, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southbay Oncology Hematology Partners, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".